We defined a selection pipeline involving all possible data combinations, and identified those genes specifically involved in the disease and minimizing variations between samples and different cell cultures. The comparison between control and NSCL/P patients yielded 56 genes. Subsequent signaling pathway analyses involving the identified genes, suggested involvement of three different pathways. In particular, we concentrated on the up-regulation of 3 candidates genes (COL15A1, PPT2, ERAP2). All expression results were confirmed by real time PCR.
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Our results suggest that expression profile differences in stem cells isolated from normal and CLP patients can identify candidate genes which had not been previously detected in the multitude of association analyses performed to date. Our work is now moving towards functional studies involving these genes. CEPID/ FAPESP, CNPq. Here, we have created a Tbx22 null mouse, which has a submucous cleft palate (SMCP), similar to the human phenotype, with a small minority showing overt clefts. In addition we find ankyloglossia and oro-nasal defects, including choanal atresia.
In the choanae the oro-nasal membrane persists or is only par- 
